- Home
- / LabGenomics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
LabGenomics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩3.6 K
2024-10-29
Market Capitalization
₩264.7 B
2024-10-29
Revenue
₩85.9 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 33.2B | 119.5B | 202.4B | 144.8B | 73.1B | 85.9B |
| Cost of goods sold | 13.7B | 41.2B | 71.0B | 48.0B | 38.1B | 51.3B |
| Gross profit | 20.3B | 78.5B | 131.9B | 97.2B | 35.3B | 43.5B |
| Gross profit margin, % | 61.1% | 65.7% | 65.2% | 67.1% | 48.2% | 50.7% |
| Operating expense total | 14.6B | 19.9B | 24.0B | 29.3B | 35.9B | 43.5B |
| Depreciation and amortization | 4.1B | 5.1B | 2.9B | 1.3B | 5.9B | 19.1B |
| EBITDA | 5.4B | 58.5B | 107.8B | 67.8B | (1.3B) | (362.7M) |
| EBITDA margin, % | 16.1% | 49.0% | 53.3% | 46.8% | -1.8% | -0.4% |
| EBIT | 1.2B | 53.1B | 104.8B | 66.4B | (8.8B) | (20.2B) |
| EBIT margin, % | 3.6% | 44.5% | 51.8% | 45.9% | -12.1% | -23.5% |
| Interest income | 274.4M | 101.0M | 154.7M | 830.9M | 4.5B | 2.1B |
| Interest expense | 415.8M | 223.8M | 208.0M | 574.0M | 5.0B | 5.5B |
| Pre tax profit | 1.1B | 51.8B | 109.1B | 63.4B | (7.1B) | (26.0B) |
| Income tax expense | 112.9M | 9.1B | 25.3B | 15.5B | 1.8B | (2.3B) |
| Net Income | 962.4M | 42.8B | 83.9B | 47.9B | (8.9B) | (23.7B) |